Kadakuntla Anusri, Wang Tiffany, Medgyesy Karen, Rrapi Enxhi, Litynski James, Adynski Gillian, Tadros Micheal
Albany Medical College, Albany Medical College, Albany, NY 12208, United States.
Division of Gastroenterology, Albany Medical Center, Albany, NY 12208, United States.
World J Gastrointest Oncol. 2021 Apr 15;13(4):238-251. doi: 10.4251/wjgo.v13.i4.238.
Colorectal cancer (CRC) is the third most diagnosed form of cancer and second most deadly cancer worldwide. Introduction of better screening has improved both incidence and mortality. However, as the coronavirus disease 2019 (COVID-19) pandemic began, healthcare resources were shunted away from cancer screening services resulting in a sharp decrease in CRC screening and a backlog of patients awaiting screening tests. This may have significant effects on CRC cancer mortality, as delayed screening may lead to advanced cancer at diagnosis. Strategies to overcome COVID-19 related disruption include utilizing stool-based cancer tests, developing screening protocols based on individual risk factors, expanding telehealth, and increasing open access colonoscopies. In this review, we will summarize the effects of COVID-19 on CRC screening, the potential long-outcomes, and ways to adapt CRC screening during this global pandemic.
结直肠癌（CRC）是全球第三大最常被诊断出的癌症类型，也是第二大致命癌症。更好的筛查方法的引入降低了发病率和死亡率。然而，随着2019年冠状病毒病（COVID-19）大流行的开始，医疗资源从癌症筛查服务中分流，导致CRC筛查急剧减少，等待筛查的患者积压。这可能对CRC癌症死亡率产生重大影响，因为筛查延迟可能导致诊断时癌症已发展到晚期。克服与COVID-19相关干扰的策略包括使用基于粪便的癌症检测、根据个体风险因素制定筛查方案、扩大远程医疗以及增加开放式结肠镜检查。在本综述中，我们将总结COVID-19对CRC筛查的影响、潜在的长期结果以及在这场全球大流行期间调整CRC筛查的方法。
